Anna Ruskova

442 total citations
15 papers, 282 citations indexed

About

Anna Ruskova is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Anna Ruskova has authored 15 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Hematology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Anna Ruskova's work include Acute Myeloid Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Anna Ruskova is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Anna Ruskova collaborates with scholars based in New Zealand, United Kingdom and Australia. Anna Ruskova's co-authors include George Chan, Leanne Berkahn, Brian Berry, Laurie H. Sehn, Joseph M. Connors, David W. Scott, Randy D. Gascoyne, Mukesh Chhanabhai, Stephen O. Brennan and Ian M. Morison and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Haematology and Haematologica.

In The Last Decade

Anna Ruskova

15 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Ruskova New Zealand 8 184 97 93 86 63 15 282
Yasuhito Suehara Japan 10 100 0.5× 75 0.8× 73 0.8× 42 0.5× 30 0.5× 34 278
Sylvie Glaisner France 8 188 1.0× 100 1.0× 124 1.3× 118 1.4× 73 1.2× 17 330
Rita Mazza Italy 12 216 1.2× 178 1.8× 71 0.8× 109 1.3× 29 0.5× 22 298
Lionello Camba Italy 6 89 0.5× 73 0.8× 151 1.6× 69 0.8× 96 1.5× 12 309
Haerim Chung South Korea 12 81 0.4× 93 1.0× 62 0.7× 46 0.5× 73 1.2× 46 352
Joël Fleury France 6 198 1.1× 168 1.7× 62 0.7× 98 1.1× 38 0.6× 7 315
NL Harris United States 5 275 1.5× 133 1.4× 163 1.8× 56 0.7× 188 3.0× 8 407
M. Lenoci Italy 7 190 1.0× 76 0.8× 212 2.3× 21 0.2× 131 2.1× 10 362
M. Angelopoulou Greece 6 196 1.1× 73 0.8× 218 2.3× 26 0.3× 84 1.3× 8 292
Carlos E. Bueso-Ramos United States 6 147 0.8× 73 0.8× 171 1.8× 23 0.3× 55 0.9× 12 334

Countries citing papers authored by Anna Ruskova

Since Specialization
Citations

This map shows the geographic impact of Anna Ruskova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ruskova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ruskova more than expected).

Fields of papers citing papers by Anna Ruskova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ruskova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ruskova. The network helps show where Anna Ruskova may publish in the future.

Co-authorship network of co-authors of Anna Ruskova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Ruskova. A scholar is included among the top collaborators of Anna Ruskova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Ruskova. Anna Ruskova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ruskova, Anna, Christin Coomarasamy, Leanne Berkahn, et al.. (2023). Diffuse large B‐cell lymphoma at risk of secondary CNS involvement: The inefficacy of intravenous high‐dose methotrexate CNS prophylaxis and the importance of baseline cerebrospinal fluid analysis. American Journal of Hematology. 98(7). 1070–1079. 5 indexed citations
2.
Ruskova, Anna, et al.. (2022). Value of cerebrospinal fluid white cell count and protein level in predicting leptomeningeal involvement by systemic aggressive B‐cell lymphoma. International Journal of Laboratory Hematology. 44(3). 490–496. 1 indexed citations
3.
Varghese, Chris, et al.. (2021). The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry. Current Oncology. 28(2). 1544–1557. 9 indexed citations
4.
Ruskova, Anna, et al.. (2021). Atezolizumab‐induced pure red cell aplasia. British Journal of Haematology. 193(1). 10–10. 6 indexed citations
5.
Ruskova, Anna, et al.. (2020). When things don't add up ‐ methotrexate unexpectedly revealed as the cause of pancytopenia. American Journal of Hematology. 95(5). 568–569. 1 indexed citations
6.
Chan, George, Anna Ruskova, Leanne Berkahn, et al.. (2019). Early treatment of acute promyelocytic leukaemia is accurately guided by the PML protein localisation pattern: real-life experience from a tertiary New Zealand centre. Pathology. 51(4). 412–420. 6 indexed citations
7.
Ruskova, Anna, et al.. (2019). Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes. Pathology. 51(5). 502–506. 7 indexed citations
8.
Ruskova, Anna, et al.. (2019). Pure erythroid leukemia: The value of E‐cadherin in making the diagnosis. American Journal of Hematology. 94(6). 726–727. 3 indexed citations
9.
Ruskova, Anna, et al.. (2015). Green neutrophil and monocyte inclusions – time to acknowledge and report. British Journal of Haematology. 170(2). 229–235. 17 indexed citations
10.
Lee, Sophie, Linda M. Graham, George Chan, & Anna Ruskova. (2012). A Diagnostic Mystery Solved by Electron Microscopy: A Case of an “Atypical” Lymphoproliferative Disorder. Ultrastructural Pathology. 36(5). 362–365. 1 indexed citations
11.
Sehn, Laurie H., David W. Scott, Mukesh Chhanabhai, et al.. (2011). Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP. Journal of Clinical Oncology. 29(11). 1452–1457. 146 indexed citations
12.
Brennan, Stephen O., et al.. (2009). A Second Case of Hb Fontainebleau [α21(B2)Ala→Pro] in an Individual with Microcytosis. Hemoglobin. 33(3-4). 258–261. 8 indexed citations
13.
Brennan, Stephen O., et al.. (2009). Deletion of five residues from the coiled coil of fibrinogen (B  Asn167_Glu171del) associated with bleeding and hypodysfibrinogenemia. Haematologica. 94(4). 585–588. 11 indexed citations
14.
Brennan, Stephen O., et al.. (2008). Novel hemoglobin α chain elongation resulting from a 15-residue insertion and tandem duplication of the F helix. Clinical Biochemistry. 41(14-15). 1156–1161. 8 indexed citations
15.
Ruskova, Anna, et al.. (2004). Aggressive Natural Killer-cell Leukemia: Report of Five Cases and Review of the Literature. Leukemia & lymphoma. 45(12). 2427–2439. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026